Farms.com Home   News

KAP President Wants Clarity On Manitoba Green Levy Deferral

The President of Keystone Agricultural Producers says he understands the province's move to defer a planned PST cut as well as its own carbon tax due to COVID-19.

Last week, Premier Brian Pallister explained the unexpected economic pressure brought on by the virus outbreak meant the provincial sales tax would not drop 1 point to 6 per cent on July 1 as originally planned, but would instead be delayed for one year. Additionally, Pallister said his government's $25 per tonne flat Green Levy would also be put on the back burner for the time-being.

"In light of circumstances that have prevailed here since Government had its budget plan announced, we understand what needs to be done in this province," said KAP President Bill Campbell. He noted however, that according to the Premier, the two initiatives are still a part of the province's plan for the future.

On that note, Campbell feels those in the ag industry would like some clarity as to which carbon tax, Manitoba's proposed flat levy or the rising federal tax, will be in effect by the time harvest hits especially since the federal rate will grow to $30 per tonne April 1st.

 

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.